What Is the Treatment for Atrophic Vaginitis and Vaginal Dryness?
Clinical Scenario
Atrophic vaginitis (urogenital atrophy) is characterised by vaginal dryness and related urogenital symptoms. The aim of treatment is effective, targeted symptom relief while minimising systemic exposure.
Treatment Approach (partial overview)
The best and most logical treatment for urogenital atrophy is local estrogen, delivered directly to the vaginal mucosa. Several distinct formulation types are available, and the prescribing rationale — including which to select, how to titrate, and whether any adjunctive measure is or is not needed — is specified in the full structured protocol.
Clinical Goals
Treatment targets substantial relief of vaginal atrophy symptoms, particularly vaginal dryness, typically within approximately 3 weeks — though some women may require 4 to 6 weeks for adequate improvement. Additional objectives include lowering of vaginal pH and improved vaginal lubrication.
References
DOI: 10.3109/13697137.2010.522875
- Vaginal dryness can be helped by simple lubricants but the best and most logical treatment for urogenital atrophy is to use local estrogen.
- Local estrogen therapy can be given as tablets, pessaries/vagitories, cream or a vaginal ring.
- Therapy is available as conjugated equine estrogens, estradiol, estriol or estrone.
- Clinicians should prescribe the lowest effective dose and caution patients not to exceed the recommended frequency of use of the chosen product, although an occasional patient may require more frequent usage to obtain a satisfactory response.
- Invariably, women will obtain substantial relief from their symptoms after about 3 weeks of treatment, although in some women it may require 4–6 weeks before adequate improvement is observed.
- Estrogen therapy lowers vaginal pH, thickens the epithelium, increases blood flow and improves vaginal lubrication.
View source ↗